MARKET

IGC

IGC

IGC Pharma Inc
AMEX
0.4148
+0.0083
+2.04%
Opening 12:19 03/28 EDT
OPEN
0.4030
PREV CLOSE
0.4065
HIGH
0.4149
LOW
0.3912
VOLUME
236.34K
TURNOVER
0
52 WEEK HIGH
0.4999
52 WEEK LOW
0.2501
MARKET CAP
27.40M
P/E (TTM)
-1.6739
1D
5D
1M
3M
1Y
5Y
'GOP Senators Tell DEA To Reject Marijuana Rescheduling, Arguing It Would Violate International Treaties' - Marijuana Moment
Three Republican senators are urging the DEA to reject a marijuana rescheduling recommendation. The senators say the U.S. Should not move cannabis from Schedule I to Schedule III. They say the move would violate international treaty obligations. Supporters and opponents of rescheduled marijuana have made competing arguments.
Benzinga · 1d ago
IGC Pharma Announces $3M Unregistered Private Placement Of 8,823,529 Shares Of Its Common Stock
IGC Pharma, Inc. Announced a $3 million strategic investment from funds managed by Bradbury Asset Management (Hong Kong) Limited. The funds will support general corporate purposes and the advancement of its investigational medicines including IGC-AD1. IGC will issue 8,823,529 shares of common stock.
Benzinga · 1d ago
'Three In Five Americans Want Congress To Pass Marijuana Banking Reform, American Bankers Associations Poll Finds Amid Renewed Push' - Marijuana Moment
A new poll from the American Bankers Association shows 63 percent of Americans support allowing marijuana businesses access to the banking system. The survey comes amid a renewed push for marijuana banking reform in Congress. The SAFER Banking Act would protect financial institutions that serve state-licensed cannabis businesses.
Benzinga · 3d ago
Weekly Report: what happened at IGC last week (0318-0322)?
Weekly Report · 3d ago
Alzheimer's-Focused Small Cap Firm IGC Pharma Releases Data, Candidate Reduces Agitation Compared To Placebo
GC Pharma Inc (IGC) announced results of an interim analysis of its ongoing Phase 2 trial of IGC-AD1 for agitation in dementia from Alzheimer's disease. The drug shows a statistically significant reduction in agitation compared to placebo in patients with the disease. In 2023, the number of Americans living with Alzheimer’s disease is estimated at 6.7 million.
Benzinga · 03/20 17:21
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
IGC Pharma, Inc. Will participate in a fire chat at the BENZINGA VIRTUAL HEALTHCARE SUMMIT 2024 on March 20, 2024. IGC Pharma is focused on Alzheimer's disease and has a pipeline of five promising drug candidates. The company's mission is to transform the landscape of Alzheimer's treatment.
Barchart · 03/20 06:00
Weekly Report: what happened at IGC last week (0311-0315)?
Weekly Report · 03/18 10:15
India Globalization Capital Welcomes New Board Member
TipRanks · 03/13 13:12
More
About IGC
IGC Pharma, Inc. is a clinical-stage pharmaceutical company. It develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer’s disease, period cramps, premenstrual syndrome, and chronic pain. Its segments include Life Sciences and Infrastructure. It has two investigational drug assets targeting Alzheimer’s disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer’s cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer’s disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol (THC) based formulation that is in a 146-person phase II clinical trial for agitation in dementia due to Alzheimer’s. TGR-63, a non-cannabinoid molecule, is an enzyme inhibitor shown in pre-clinical trials to reduce neurotoxicity in Alzheimer’s cell lines. It also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

Webull offers IGC Pharma Inc stock information, including AMEX: IGC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IGC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IGC stock methods without spending real money on the virtual paper trading platform.